Biotech
Aug. 28, 2014
Adapting to an inter partes review world
Less than two years after implementation of inter partes review proceedings at the USPTO, the judges who conduct the proceeding have been likened to "death squads that kill property rights." By Judy M. Mohr
Less than two years after implementation of inter partes review (IPR) proceedings at the U.S. Patent and Trademark Office, the judges on the Patent Trial and Appeal Board (PTAB) that conducts the proceeding have been likened to "death squads that kill property rights." Indeed, 17 patents in the first 20 patents challenged in an IPR and taken to a final written decision by the PTAB suffered an inglorious death.
Biote...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In